The risk of tumorigenesis or cancer predisposition due to RTEL1 mutations is not only observed in the case of HHS or DC, but interestingly, it has also been connected to the predisposition for brain malignancies like gliomas, astrocytomas, and glioblastomas [16–18]. The gene discussed is RTEL1; the disease is central nervous system cancer.